COMMUNIQUÉS West-GlobeNewswire

Radient Technologies Inc. Issues Shares for Services
24/04/2019
EDMONTON, Alberta, April 24, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI; OTCQX: RDDTF ) has issued an aggregate of 249,743 common shares to third party consultants [...]
Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2019
24/04/2019
SAN DIEGO and TORONTO, April 24, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes [...]
Nephros to Present at Taglich Brothers 16th Annual Investment Conference on April 30, 2019 in New York City
24/04/2019
SOUTH ORANGE, NJ, April 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical [...]
Pacific Biosciences Launches New Sequel II System, Featuring ~8 Times the DNA Sequencing Data Output
24/04/2019
New system is ideally suited for comprehensive variant detection, large genome de novo assembly, human structural variant characterization, whole transcriptome analysis, and more MENLO PARK, Calif., April 24, 2019 ( [...]
Active Biotech: NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
24/04/2019
PRESS RELEASE The Board of Directors of Active Biotech AB (publ) has issued a notice to the Annual General Meeting, which is to take place on Thursday, May 23, 2019, at 5 pm at the company's offices, Scheelevägen 22 in [...]
BioCryst to Report First Quarter 2019 Financial Results on May 8
24/04/2019
RESEARCH TRIANGLE PARK, N.C., April 24, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2019 financial results on Wednesday, May 8, [...]
Akcea Therapeutics to Hold First Quarter 2019 Financial Results Webcast
24/04/2019
Webcast scheduled for Wednesday, May 8th at 4:30 p.m. Eastern Time BOSTON, April 24, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that it [...]
BioVie to Present at ThinkEquity Conference in NYC on May 2nd
24/04/2019
LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- BioVie Inc. (OTCQB: BIVI) (“BioVie” or “Company”), a clinical-stage company developing innovative drug therapies for liver disease, announced that Mr. Terren Peizer, the [...]
Aclaris Therapeutics Announces Issuance of a Patent Covering the use of Ruxolitinib and its Deuterated Forms to Treat Alopecia Areata
24/04/2019
WAYNE, Pa., April 24, 2019 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory and dermatological diseases, today announced that the [...]
Surface Oncology Management to Present at the Solebury Trout Class of 2018 Biotech IPOs Investor Day
24/04/2019
CAMBRIDGE, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Kane Biotech Announces New Sales Representation by SLA Brands
24/04/2019
WINNIPEG, Manitoba, April 24, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of [...]
Sharps Compliance Reports Fiscal 2019 Third Quarter Results
24/04/2019
Third quarter 2019 revenue was $9.5 million, a slight increase over the prior year revenue Net loss of $1.1 million and net loss per share of $0.07 for the quarter Route-based business increased 20% MedSafe collection [...]
Precision BioSciences Announces Presentations at the 22nd Annual Meeting of the American Society of Gene & Cell Therapy
24/04/2019
DURHAM, N.C., April 24, 2019 (GLOBE NEWSWIRE) -- Precision BioSciences (Nasdaq: DTIL) (“Precision”), a genome editing company dedicated to improving life (DTIL) through its proprietary ARCUS ® genome editing platform, [...]
ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies
24/04/2019
Distribution agreement for Tru Niagen (nicotinamide riboside) in Vancouver area provides access to high-end pharmacies and clinics LOS ANGELES, April 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced [...]
Integra LifeSciences Reports First Quarter 2019 Financial Results
24/04/2019
Reported revenues amounted to $359.7 million; organic revenues increased 3.1% GAAP and adjusted earnings per diluted share were $0.38 and $0.65, respectively The Company reaffirms reported and organic revenue guidance [...]
Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019
24/04/2019
BEDMINSTER, N.J. and DUBLIN, Ireland, April 24, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that it will host a [...]
Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board
24/04/2019
Press release, Helsinki, 24 April 2019 at 9.30 am (EET) Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board Nexstim Plc (NXTMH:HEX, NXTMS:STO), the targeted neuromodulation company developing and [...]
CellaVision AB presents the first quarter for 2019 on May 7 at 11:00 CET
24/04/2019
The information was submitted to the public on April 24, 2018 at 8:20 CET CellaVision AB (publ) will publish the interim report for the first quarter on May 7, 2019 at 8:20 CET. The report will be available at www. [...]
Interim report for the first 3 months of 2019
24/04/2019
Please read the full announcement in the attached PDF Attachment 2019_07_Q12019_CompanyAnnouncement_EN_FINAL

Pages